scholarly article | Q13442814 |
P356 | DOI | 10.3109/1354750X.2012.699554 |
P698 | PubMed publication ID | 22793493 |
P50 | author | Coonoor Chandrasekar | Q80649310 |
P2093 | author name string | Q Ding | |
O K Idowu | |||
Q Yin | |||
A F G Taktak | |||
P2860 | cites work | Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness. | Q55055140 |
Cancer-related inflammation | Q27860907 | ||
Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients | Q31021361 | ||
Prognostic impact of lymphocytes in soft tissue sarcomas | Q33813250 | ||
The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas | Q33842051 | ||
A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients | Q34041858 | ||
YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma | Q34065323 | ||
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas | Q34178633 | ||
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis | Q34188723 | ||
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival | Q34557280 | ||
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. | Q34627925 | ||
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients | Q35121634 | ||
Macrophage infiltration predicts a poor prognosis for human ewing sarcoma | Q35168030 | ||
Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis | Q35242640 | ||
D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma | Q35579727 | ||
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas | Q35661688 | ||
Prognostic impacts of hypoxic markers in soft tissue sarcoma | Q35789146 | ||
Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. | Q35803084 | ||
Soft-tissue sarcomas in adults | Q36233720 | ||
Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients | Q36612348 | ||
Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation | Q37878299 | ||
Use of inflammatory markers to guide cancer treatment. | Q37903224 | ||
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents | Q39581986 | ||
The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study | Q39692688 | ||
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer | Q42985641 | ||
Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients | Q43568993 | ||
Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer | Q43599505 | ||
Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma | Q44754380 | ||
A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern | Q47387905 | ||
Earlier diagnosis of bone and soft-tissue tumours | Q51642229 | ||
Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma. | Q53390333 | ||
Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas. | Q53433472 | ||
P433 | issue | 6 | |
P304 | page(s) | 539-544 | |
P577 | publication date | 2012-07-16 | |
P1433 | published in | Biomarkers | Q4915076 |
P1476 | title | Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma | |
P478 | volume | 17 |
Q42378704 | A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities |
Q98946368 | Analysis of prognostic factors in soft tissue sarcoma: Cancer registry from a single tertiary hospital in Indonesia. A retrospective cohort study |
Q64096473 | Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study |
Q91947378 | Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial |
Q58790889 | Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma |
Q53179198 | Diagnostic value of neutrophil-lymphocyte and albumin-globulin ratios in canine soft tissue sarcoma. |
Q41259916 | Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients |
Q42238045 | Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. |
Q38742533 | Immune Therapy for Sarcomas |
Q41072346 | Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma. |
Q89823485 | Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis |
Q64242357 | Neutrophil: Lymphocyte ratio and oral squamous cell carcinoma: A preliminary study |
Q90328743 | PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC |
Q34226276 | Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis |
Q35813764 | Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma |
Q35797850 | Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma |
Q54542035 | Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. |
Q38719404 | Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma |
Q27022482 | Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis |
Q58698876 | Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection |
Q42270431 | Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy |
Q58759331 | Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis |
Q46838204 | Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy |
Q56511945 | RETRACTED: Preoperative neutrophil-to-lymphocyte ratio for prognostication of patients with distal bile duct carcinomas undergoing surgery |
Q50442804 | Stewart-Treves syndrome following idiopathic leg lymphoedema: remember sarcoma. |
Q43588659 | The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma |
Q37507488 | The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer |
Q91615248 | The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma |
Q47338550 | The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. |